Identification of Novel Thiocarboxanilide Derivatives That Suppress a Variety of Drug-Resistant Mutant Human Immunodeficiency Virus Type 1 Strains at a Potency Similar to That for Wild-Type Virus.
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.40.6.1454
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 1996
Authors
Publisher
American Society for Microbiology